ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,390,113 | -11.6% | 309,142 | +0.2% | 0.02% | -4.8% |
| Q2 2023 | $9,485,810 | -13.0% | 308,582 | +2.0% | 0.02% | -16.0% |
| Q1 2023 | $10,899,435 | -8.4% | 302,510 | +0.4% | 0.02% | -13.8% |
| Q4 2022 | $11,903,819 | +2.0% | 301,210 | +3.7% | 0.03% | -3.3% |
| Q3 2022 | $11,673,000 | -4.4% | 290,530 | 0.0% | 0.03% | 0.0% |
| Q2 2022 | $12,214,000 | +10.3% | 290,530 | +2.2% | 0.03% | +42.9% |
| Q1 2022 | $11,074,000 | -0.6% | 284,235 | +1.7% | 0.02% | +5.0% |
| Q4 2021 | $11,137,000 | +25.5% | 279,463 | +13.8% | 0.02% | +17.6% |
| Q3 2021 | $8,873,000 | -11.1% | 245,520 | +0.8% | 0.02% | -10.5% |
| Q2 2021 | $9,983,000 | +8.7% | 243,550 | +15.7% | 0.02% | +5.6% |
| Q1 2021 | $9,185,000 | +634.2% | 210,575 | +742.3% | 0.02% | +500.0% |
| Q4 2020 | $1,251,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |